Diabetes

New dietary guidelines emphasize higher protein intake, reduced added sugars, and avoidance of ultra-processed foods to combat chronic diseases.

Gestational diabetes disrupts RNA splicing in the placenta, revealing potential targets for improving pregnancy outcomes.

Lowering blood glucose levels significantly reduces heart disease risks in prediabetes, offering new hope for prevention and management strategies.

The most impactful FDA approvals of 2025 feature groundbreaking treatments for mental health, STIs, diabetes, pain relief, and cardiovascular health.

Effective Nutrition Strategies for Diabetes Management Focus on Personalized Dietary Approaches to Enhance Glycemic Control and Overall Health

Pharmacists can enhance patient care through integrated treatment strategies.

In a phase 2 trial, the unimolecular agonist of GLP-1 and amylin induced major reductions in weight loss and hemoglobin A1c in patients with type 2 diabetes.

New research reveals how age, lifestyle, and diabetes alter the gluteus maximus shape, highlighting sex-specific responses and metabolic health implications.

New research shows that an increased consumption of ultraprocessed foods significantly raises prediabetes risk in young adults, highlighting urgent dietary intervention needs.

Nazia Somani Babul, PharmD, BCACP, often serves as a primary or coinvestigator and collaborates with pharmacists, students, and residents.

Metformin may hinder exercise benefits, impacting blood vessel function and insulin control, raising concerns for diabetes management during physical activity.

Researchers unveil a pharmacist-led intervention to enhance hypoglycemia management in older adults with type 2 diabetes, improving patient outcomes.

Maternal type 1 diabetes may influence children's DNA, potentially reducing their risk of developing islet autoimmunity.

Low-dose aspirin significantly reduces heart attack, stroke, and death risks in adults with type 2 diabetes and elevated cardiovascular risk.

Explore the rising prevalence of diabetes in the US, its various types, and the critical role pharmacists play in patient care.

Environmental factors significantly influence the rising rates of type 2 diabetes in children.

Inhaled insulin Afrezza offers a rapid-acting alternative for children with type 1 diabetes, enhancing blood glucose control and patient satisfaction.

Research reveals that poor glycemic control in adolescents with type 1 diabetes significantly increases the risk of developing neuropathy in adulthood.

Biolinq Shine, a wearable biosensor, revolutionizes diabetes management with real-time glucose, activity, and sleep tracking.

GLP-1 receptor agonists enhance glycemic control and weight management in youth with type 2 diabetes (T2D) and obesity; however, safety concerns persist.

Researchers uncover a brain circuit linking stress to increased blood glucose, revealing insights into stress's role in type 2 diabetes (T2D) development.

Individuals with learning disabilities face a heightened risk of severe type 2 diabetes (T2D), leading to increased mortality despite better glycemic control.

An international BMJ panel recommended broader use of SGLT-2 inhibitors and GLP-1 receptor agonists.

The sensor detects acetone levels in the breath to indicate diabetes.

Simplifying complex information through illustrations and storytelling helps patients feel that managing their condition is achievable.